Westwood Holdings Group Inc / ABT
Westwood Holdings Group Inc’s Abbott Laboratories Position
Does Westwood Holdings Group Inc own Abbott Laboratories (ABT)? Yes — 504.6K shares worth $52M (+0.38% of its 13F portfolio) as of Q1 2026, down from 645.4K shares the prior filed quarter.
Position Value
$52M
Q1 2026
Shares
504.6K
% of Portfolio
+0.38%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 504.6K | $52M | +0.38% |
| Q4 2025 | 645.4K | $81M | +0.66% |
| Q3 2025 | 882.0K | $118M | +0.84% |
| Q2 2025 | 1.07M | $145M | +1.08% |
| Q1 2025 | 1.19M | $157M | +1.19% |
| Q4 2024 | 1.40M | $158M | +1.22% |
| Q3 2024 | 1.40M | $160M | +0.67% |
| Q2 2024 | 1.42M | $147M | +0.69% |
| Q1 2024 | 1.21M | $137,849 | +1.09% |
| Q4 2023 | 1.33M | $146,439 | +1.24% |
| Q3 2023 | 1.30M | $125,828 | +1.17% |
| Q2 2023 | 925.9K | $100,940 | +0.90% |
| Q1 2023 | 268.4K | $27,182 | +0.24% |
| Q4 2022 | 271.2K | $29,778 | +0.26% |
| Q3 2022 | 272.4K | $26M | +0.31% |
| Q2 2022 | 274.7K | $30M | +0.33% |
| Q1 2022 | 285.1K | $34M | +0.31% |
| Q4 2021 | 282.6K | $40M | +0.36% |
| Q3 2021 | 287.0K | $34M | +0.37% |
| Q2 2021 | 292.2K | $34M | +0.34% |
| Q1 2021 | 861.8K | $103M | +1.04% |
| Q4 2020 | 865.3K | $95M | +1.10% |
| Q3 2020 | 1.15M | $125M | +1.58% |
| Q2 2020 | 884.8K | $81M | +1.07% |
| Q1 2020 | 1.05M | $83M | +1.25% |
| Q4 2019 | 1.14M | $99M | +1.05% |
| Q3 2019 | 1.13M | $95M | +1.04% |
| Q2 2019 | 1.14M | $96M | +1.05% |
| Q1 2019 | 2.27M | $181M | +1.88% |
| Q4 2018 | 2.52M | $183M | +2.08% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Westwood Holdings Group Inc’s full portfolio or all institutional holders of ABT.